复星医药现金流压力下创新药豪赌 12.56亿元出售资产难填96亿元窟窿?

华夏时报
3 hours ago

9月26日,复星医药发布公告称,公司控股子公司复星医药产业拟筹划转让上海克隆100%股权,交易对价不超过12.56亿元。  这已是复星医药今年来又一笔资产处置。  截至2025年上半年,公司已签约处置项目总额超20亿元,这一切都指向了同一个目标——补充现金流,为创新药转型续航。  据公告,这笔交易采用了一种复杂的设计——先设立基金,再转让资产。  复星医药产业将作为有限合伙人(LP)现金出资...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10